Research ArticleNEUROPSYCHOLOGY
Prefrontal inputs to the amygdala instruct fear extinction memory formation
- Olena Bukalo1,2,*,
- View ORCID ProfileCourtney R. Pinard1,
- View ORCID ProfileShana Silverstein1,2,
- Christina Brehm3,
- Nolan D. Hartley4,
- Nigel Whittle3,
- Giovanni Colacicco1,
- Erica Busch1,
- Sachin Patel4,
- Nicolas Singewald3 and
- Andrew Holmes1
- 1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
- 2Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- 3Department of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82/III, A-6020 Innsbruck, Austria.
- 4Department of Psychiatry and Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- ↵*Corresponding author. E-mail: bukalool{at}mail.nih.gov
See allHide authors and affiliations
Science Advances 31 Jul 2015:
Vol. 1, no. 6, e1500251
DOI: 10.1126/sciadv.1500251
Vol. 1, no. 6, e1500251
DOI: 10.1126/sciadv.1500251
Olena Bukalo
1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
2Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Courtney R. Pinard
1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
Shana Silverstein
1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
2Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Christina Brehm
3Department of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82/III, A-6020 Innsbruck, Austria.
Nolan D. Hartley
4Department of Psychiatry and Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Nigel Whittle
3Department of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82/III, A-6020 Innsbruck, Austria.
Giovanni Colacicco
1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
Erica Busch
1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
Sachin Patel
4Department of Psychiatry and Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Nicolas Singewald
3Department of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82/III, A-6020 Innsbruck, Austria.
Andrew Holmes
1Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20853, USA.
